11 research outputs found
Tension-free Vaginal TapeâObturator for Treatment of Pure Urodynamic Stress Urinary Incontinence: Efficacy and Adverse Effects at 10-year Follow-up
Background Inside-out transobturator tape (tension-free vaginal tapeâobturator [TVT-O]) is currently one of the most effective and popular procedures for the surgical treatment of female stress urinary incontinence (SUI). However, data reporting long-term outcomes are lacking. Objective To assess the efficacy and safety of TVT-O 10 yr after implantation for the treatment of female pure SUI. Design, setting, and participants A multicenter, prospective study was conducted in five tertiary referral centers in three countries. All consecutive women with urodynamically proven pure SUI treated by TVT-O were included. Patients with mixed incontinence and/or anatomic evidence of pelvic organ prolapse were excluded. Intervention TVT-O implantation. Outcome measurements and statistical analysis Data regarding subjective outcomes (International Consultation on Incontinence QuestionnaireâShort Form, Patient Global Impression of Improvement, and patient satisfaction scores), objective cure (stress test) rates, and adverse events were collected during follow-up. Univariable analysis was performed to investigate outcomes. Results and limitations One hundred sixty-eight women had TVT-O implantation. At 10-yr follow-up, 160 patients (95%) were available for the evaluation. We did not find any significant change of the surgical outcomes during this time. At 10 yr after surgery, 155 of 160 patients (97%) declared themselves cured (p = 0.7). Similarly, at 10-yr evaluation, 148 of 160 patients (92%) were objectively cured. No significant deterioration of objective cure rates was observed over time (p = 0.4). The history of failure of previous anti-incontinence procedures (hazard ratio: 5.34; 95% CI, 2.61â11.9; p = 0.009) was the only predictor of recurrence of SUI. The onset of de novo overactive bladder was reported by 23 of 160 patients (14%) at 10-yr follow-up. No other late complications were reported. Conclusions The 10-yr results of this study showed that TVT-O is a highly effective and safe option for the treatment of SUI. Patient summary At long-term follow up, tension-free vaginal tape-obturator is highly effective and safe for the treatment of stress urinary incontinence. © 2016 European Association of Urolog
Maternal serum and umbilical cord blood leptin concentration with fetal growth restriction
OBJECTIVE: To ascertain whether fetal growth restriction is
associated with alterations of leptin concentrations in umbilical
cord blood and maternal serum.
METHODS: Maternal serum and umbilical cord blood leptin
concentrations were determined by immunoradiometric
assay at term in 43 women with uncomplicated singleton
pregnancies (group A) and in 27 women with singleton
pregnancies complicated by fetal growth restriction (group
B), all with normal pregravid body mass index (BMI).
RESULTS: Maternal serum leptin concentrations were significantly
higher in group B compared with group A (45.0
ng/mL [range 34.2â54.9] versus 29.0 ng/mL [range 24.7â
33.3]; P < .01). Umbilical cord blood leptin levels were
significantly lower in group B compared with group A (8.4
ng/mL [range 3.6 â13.2] versus 13.1 ng/mL [9.7â16.5]; P <
.01). Maternal serum leptin levels were not significantly
correlated with maternal BMI or with neonatal birth
weight in either group. Umbilical cord blood leptin concentrations
were significantly correlated with neonatal birth
weight in both groups.
CONCLUSION: Growth restricted fetuses at term show umbilical
cord blood leptin concentrations significantly
lower than those in normal fetuses, suggesting that fetal
adipose tissue is a major source of leptin. Maternal serum
leptin concentrations are higher in the presence of a
growth restricted fetus. This increase might be due to an
intrinsic placental mechanism, by which small placentas
produce more leptin as a compensatory mechanism, or
to early hypoxia. (Obstet Gynecol 2003;102:535â 43.
© 2003 by The American College of Obstetricians and
Gynecologists.
Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women.
OBJECTIVE: The aim of this study was to evaluate the effects of estrogen-progestin therapy on serum levels of receptor-activating nuclear factor kappabeta ligand (RANKL), osteoprotegerin, osteocalcin, leptin, and ghrelin in a cross-sectional study of 99 healthy postmenopausal women conducted at the Menopause Clinic of our department. DESIGN: In this cross-sectional, observational study, 99 participants were divided into two groups. Group A was composed of 77 postmenopausal women who had never received estrogen-progestin therapy, and group B was composed of 22 postmenopausal women who had received transdermal 17beta-estradiol at a dose of 50 microg/day in a continuous regimen for at least 24 months and nomegestrol at a dose of 5 mg/day for 12 days/month in a sequential regimen. All participants underwent blood sampling in the morning and quantitative ultrasound bone-densitometry measurement of the proximal phalanges of the dominant hand. RESULTS: T score and amplitude-dependent speed of sound were significantly higher in group B than in group A. No significant differences in RANKL, osteoprotegerin, and osteocalcin were observed between the two groups. Serum leptin levels were significantly lower in group B than in group A, whereas ghrelin was significantly higher in group B than in group A. CONCLUSIONS: The data gathered in this preliminary study indicate that estrogen-progestin therapy may protect against postmenopausal bone loss, but this protective effect does not seem to be exerted through action on the RANK-RANKL-osteoprotegerin system. Similarly, although several reports suggest that leptin and ghrelin are involved in bone metabolism, we could not detect any important correlation of these two hormones with bone metabolism or bone status in treated and untreated postmenopausal women. Because of the limited number of treated participants and the study design, the results of this preliminary study must be confirmed in larger, prospective, longitudinal studies